Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window - PubMed (original) (raw)
Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window
Young-Mi Yu et al. Stroke. 2005 Oct.
Abstract
Background and purpose: Ethyl pyruvate (EP) is a pyruvate derivative that has been reported recently to prevent lethality in mice with established lethal sepsis and systemic inflammation. In this study, we examined the neuroprotective effect of EP in a rat cerebral ischemia model of middle cerebral artery occlusion (MCAO).
Methods: Male Sprague-Dawley rats were subjected to 1 hour of MCAO, and EP was administered at various time points before or after MCAO. The changes in the brain infarction, neurological deficits, microglia activation, and proinflammatory cytokine expression were evaluated. BV2 microglial cells were also used to access the anti-inflammatory effect of EP.
Results: The administration of EP intraperitoneally at 30 minutes before or at 4 or 12 hours after MCAO reduced the infarct volume to 10.3+/-3.4% (n=6; P<0.05), 21.5+/-2.7% (n=6; P<0.05), and 44.3+/-4.0% (n=6; P<0.05), respectively, of that of the control group. The significant reduction in infarct volume was accompanied by the suppression of the clinical manifestations associated with cerebral ischemia, including motor impairment and neurological deficits, microglial activation, and proinflammatory cytokine expression. The neuroprotective effect of EP was yet evident when it was administered as late as 24 hours after MCAO/reperfusion (76.5+/-4.70%; n=6; P<0.05). EP suppressed lipopolysaccharide induced activation of BV2 cells, as was evidenced by a reduction in NO release and the accompanying induction of proinflammatory cytokines.
Conclusions: These results suggest that EP affords the strong protection of the delayed cerebral ischemic injury with a wide therapeutic window.
Similar articles
- Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Kim SW, Jeong JY, Kim HJ, Seo JS, Han PL, Yoon SH, Lee JK. Kim SW, et al. Neurotox Res. 2010 Jan;17(1):39-49. doi: 10.1007/s12640-009-9075-4. Epub 2009 Jul 28. Neurotox Res. 2010. PMID: 19636661 - Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain.
Kim JB, Yu YM, Kim SW, Lee JK. Kim JB, et al. Brain Res. 2005 Oct 26;1060(1-2):188-92. doi: 10.1016/j.brainres.2005.08.029. Epub 2005 Oct 13. Brain Res. 2005. PMID: 16226231 - Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain.
Lee HK, Park JY, Lee H, Kim ID, Kim SW, Yoon SH, Lee JK. Lee HK, et al. Neurotherapeutics. 2019 Apr;16(2):523-537. doi: 10.1007/s13311-019-00711-w. Neurotherapeutics. 2019. PMID: 30680637 Free PMC article. - Ethyl pyruvate: A newly discovered compound against ischemia-reperfusion injury in multiple organs.
Lu C, Wang C, Xiao H, Chen M, Yang Z, Liang Z, Wang H, Liu Y, Yang Y, Wang Q. Lu C, et al. Pharmacol Res. 2021 Sep;171:105757. doi: 10.1016/j.phrs.2021.105757. Epub 2021 Jul 21. Pharmacol Res. 2021. PMID: 34302979 Review. - Therapeutic effects of herbal compounds in cerebral ischemia with special reference to suppression of microglia activation implicated in neurodegeneration.
Jia WJ, Yuan Y, Wu CY. Jia WJ, et al. Histol Histopathol. 2019 Sep;34(9):965-983. doi: 10.14670/HH-18-103. Epub 2019 Mar 22. Histol Histopathol. 2019. PMID: 30900737 Review.
Cited by
- Long-lasting inhibition of presynaptic metabolism and neurotransmitter release by protein S-nitrosylation.
Rudkouskaya A, Sim V, Shah AA, Feustel PJ, Jourd'heuil D, Mongin AA. Rudkouskaya A, et al. Free Radic Biol Med. 2010 Sep 1;49(5):757-69. doi: 10.1016/j.freeradbiomed.2010.05.032. Epub 2010 Jun 8. Free Radic Biol Med. 2010. PMID: 20633346 Free PMC article. - Pitfalls in the quest of neuroprotectants for the perinatal brain.
Gressens P, Le Verche V, Fraser M, Rousset CI, Schwendimann L, Bennet L, George SA, Wang X, Mallard C, Tilley BC, Dournaud P, Gunn AJ, Hagberg H, Levison SW. Gressens P, et al. Dev Neurosci. 2011;33(3-4):189-98. doi: 10.1159/000333109. Epub 2011 Sep 30. Dev Neurosci. 2011. PMID: 21968048 Free PMC article. - Ethyl Pyruvate-Derived Transdifferentiation of Astrocytes to Oligodendrogenesis in Cuprizone-Induced Demyelinating Model.
He Y, An J, Yin JJ, Miao Q, Sui RX, Han QX, Ding ZB, Huang JJ, Ma CG, Xiao BG. He Y, et al. Neurotherapeutics. 2021 Jan;18(1):488-502. doi: 10.1007/s13311-020-00947-x. Epub 2020 Nov 2. Neurotherapeutics. 2021. PMID: 33140235 Free PMC article. - Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.
Keshari KR, Wilson DM. Keshari KR, et al. Chem Soc Rev. 2014 Mar 7;43(5):1627-59. doi: 10.1039/c3cs60124b. Epub 2013 Dec 20. Chem Soc Rev. 2014. PMID: 24363044 Free PMC article. Review. - Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Kim SW, Jeong JY, Kim HJ, Seo JS, Han PL, Yoon SH, Lee JK. Kim SW, et al. Neurotox Res. 2010 Jan;17(1):39-49. doi: 10.1007/s12640-009-9075-4. Epub 2009 Jul 28. Neurotox Res. 2010. PMID: 19636661
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources